Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study
Inflammatory Bowel Diseases · 2026
DOI: 10.1093/ibd/izag021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Bowel Diseases, 2026. Verfasst von Akshita Gupta und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States. Hauptthemen laut MEDLINE: Artificial Intelligence, Inflammatory Bowel Diseases, Clinical Trials as Topic, Patient Selection. Die Arbeit nennt 10 Literaturangaben.
Abstract (Originalsprache)
Lay Summary An LLM-based AI tool significantly improved identification of potentially eligible patients and screening efficiency for IBD clinical trials, outperforming physician referrals by screening electronic medical records and generating ranked candidate lists based on trial inclusion/exclusion criteria, thereby enhancing trial recruitment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- Medicine Clinical Trials Office, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- Institute for Healthcare Delivery Science, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- The Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, United States.
- The Windreich Department of Artificial Intelligence and Human Health, Mount Sinai Medical Center, New York, NY, United States.
ORCID-Profile: Akshita Gupta, Ryan C Ungaro, Jean-Frederic Colombel, Robert Freeman, Girish N Nadkarni
Zitieren
APA
Gupta, A., Ungaro, R. C., Steinlauf, A., Colombel, J. F., Feldman, S., Leviton, A., Onyuka, A., Mar, P., Cohen, M., Freeman, R., Nadkarni, G. N., & Klang, E. (2026). Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study. Inflammatory Bowel Diseases. https://doi.org/10.1093/ibd/izag021
Vancouver
Gupta A, Ungaro RC, Steinlauf A, Colombel JF, Feldman S, Leviton A, et al. Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study. Inflammatory Bowel Diseases. 2026. doi:10.1093/ibd/izag021
BibTeX
@article{Gupta2026,
author = {Gupta, Akshita and Ungaro, Ryan C and Steinlauf, Adam and Colombel, Jean-Frederic and Feldman, Sari and Leviton, Asher and Onyuka, Alberta and Mar, Phyu and Cohen, Michele and Freeman, Robert and Nadkarni, Girish N and Klang, Eyal},
title = {Artificial intelligence enhances screening efficiency for inflammatory bowel disease clinical trials: a prospective study},
journal = {Inflammatory Bowel Diseases},
year = {2026},
doi = {10.1093/ibd/izag021}
}
EUVIMED